Perlmutter_CC's profile picture. We combine visionary thinking and compassionate care with the science of treating cancer. An NCI-designated Comprehensive Cancer Center, part of @NYULangone

Perlmutter Cancer Center at NYU Langone Health

@Perlmutter_CC

We combine visionary thinking and compassionate care with the science of treating cancer. An NCI-designated Comprehensive Cancer Center, part of @NYULangone

Perlmutter Cancer Center at NYU Langone Health repostou

Tune in at 2:30pm East as @DrMarcSiegel catches up on the latest #breastcancer news with @nyulangone's @Elizabeth_Comen. Stream here: sxm.app.link/DoctorRadio


Perlmutter Cancer Center at NYU Langone Health repostou

We are recruiting!  Feel free to DM/contact me! Heme Malignancies/Stem Cell Transplant/Cell Therapy Assist/Assoc/Full Professor Faculty in Heme Malignancies and/or Cellular Therapy/Stem Cell Transplant (including leadership roles) primarily at NYU Langone Hospital-Long Island

JohnPLeonardMD's tweet image. We are recruiting!  Feel free to DM/contact me! 
Heme Malignancies/Stem Cell Transplant/Cell Therapy Assist/Assoc/Full Professor Faculty in Heme Malignancies and/or Cellular Therapy/Stem Cell Transplant (including leadership roles) primarily at NYU Langone Hospital-Long Island

Perlmutter Cancer Center at NYU Langone Health repostou

Do you have questions about pancreatic cancer? Medical Grand Rounds is LIVE. @DrHLofton is talking with Dr. Brock Hewitt @NYUGSOM and they are taking your calls at 877-698-3627. Shy? Email [email protected] sxm.app.link/DoctorRadio

NYUDocs's tweet image. Do you have questions about pancreatic cancer? Medical Grand Rounds is LIVE. @DrHLofton is talking with Dr. Brock Hewitt @NYUGSOM and they are taking your calls at 877-698-3627. Shy? Email docs@siriusxm.com  sxm.app.link/DoctorRadio

Perlmutter Cancer Center at NYU Langone Health repostou

During #LungCancerAwarenessMonth, we are pleased to present an important study demonstrating the feasibility & efficacy of a hypofractionated course of #proton reirradiation for recurrent thoracic tumors: sciencedirect.com/science/articl… @sheba_medical @Perlmutter_CC @The_BMC @ProCureNJ

theijpt's tweet image. During #LungCancerAwarenessMonth, we are pleased to present an important study demonstrating the feasibility & efficacy of a hypofractionated course of #proton reirradiation for recurrent thoracic tumors: sciencedirect.com/science/articl… @sheba_medical @Perlmutter_CC @The_BMC @ProCureNJ

Perlmutter Cancer Center at NYU Langone Health repostou

Excited to serve as the 2026-2028 Vice-Chair of the @ASTCT Committee on Education and Content. Join us on December 2 at 12pm CST for a webinar on Innovations in CAR T cell therapy with @MichaelDJain and @Kyttaro_Therapy. @Perlmutter_CC learn.astct.org/products/innov…


Perlmutter Cancer Center at NYU Langone Health repostou

Very proud of members of our @Perlmutter_CC @nyulangone Gastrointestinal Cancer team that delivers exceptional care each day for all of our patients with pancreatic and GI cancers. #WPCD

Aiims1742's tweet image. Very proud of members of our @Perlmutter_CC @nyulangone Gastrointestinal Cancer team that delivers exceptional care each day for all of our patients with pancreatic and GI cancers. #WPCD
Aiims1742's tweet image. Very proud of members of our @Perlmutter_CC @nyulangone Gastrointestinal Cancer team that delivers exceptional care each day for all of our patients with pancreatic and GI cancers. #WPCD

Perlmutter Cancer Center at NYU Langone Health repostou

Dr. Minas Economides (@minaseconomides @nyulangone @Perlmutter_CC) highlighted LITESPARK-005 showing a 26% reduction in progression risk with belzutifan, and discussed how integrating HIF-2α inhibition with CAIX-targeted imaging may clarify ccRCC biology. #DAVAGU

DAVAOnc's tweet image. Dr. Minas Economides (@minaseconomides @nyulangone @Perlmutter_CC) highlighted LITESPARK-005 showing a 26% reduction in progression risk with belzutifan, and discussed how integrating HIF-2α inhibition with CAIX-targeted imaging may clarify ccRCC biology. #DAVAGU
DAVAOnc's tweet image. Dr. Minas Economides (@minaseconomides @nyulangone @Perlmutter_CC) highlighted LITESPARK-005 showing a 26% reduction in progression risk with belzutifan, and discussed how integrating HIF-2α inhibition with CAIX-targeted imaging may clarify ccRCC biology. #DAVAGU
DAVAOnc's tweet image. Dr. Minas Economides (@minaseconomides @nyulangone @Perlmutter_CC) highlighted LITESPARK-005 showing a 26% reduction in progression risk with belzutifan, and discussed how integrating HIF-2α inhibition with CAIX-targeted imaging may clarify ccRCC biology. #DAVAGU
DAVAOnc's tweet image. Dr. Minas Economides (@minaseconomides @nyulangone @Perlmutter_CC) highlighted LITESPARK-005 showing a 26% reduction in progression risk with belzutifan, and discussed how integrating HIF-2α inhibition with CAIX-targeted imaging may clarify ccRCC biology. #DAVAGU

Perlmutter Cancer Center at NYU Langone Health repostou

Last reminder: We’ll see you bright and early at 9:30 AM EST on the 25th to kick off #chromatin2025! Fantastic lineup of speakers with discussion to follow each talk. Don’t forget to register for this virtual meeting if you haven’t yet: bit.ly/chromatin-2025

jane_skok's tweet image. Last reminder: We’ll see      you bright and early at 9:30 AM EST on the 25th to kick off #chromatin2025!      Fantastic lineup of speakers with discussion to follow each talk. Don’t forget to register for this virtual meeting if you haven’t yet: bit.ly/chromatin-2025

Perlmutter Cancer Center at NYU Langone Health repostou

HACC and HMS AI in Medicine Event I helped organize feature Hellenic Experts in Medical AI which is revolutionizing the healthcare of the future. hellenicamerican.cc/event-details/…

lymberis's tweet image. HACC and HMS AI in Medicine Event I helped organize feature Hellenic Experts in Medical AI which is revolutionizing the healthcare of the future.
 hellenicamerican.cc/event-details/…

Even after cancer treatment ends, the fear that it might return can feel heavy and persistent. Join Karen Sheinkopf, LCSW and Michael Shusterman, MD (@guildsman) to learn how to cope with fear of #recurrence & #scanxiety in cancer #survivorship. RSVP: i.nyulangone.org/b9u

Perlmutter_CC's tweet image. Even after cancer treatment ends, the fear that it might return can feel heavy and persistent. Join Karen Sheinkopf, LCSW and Michael Shusterman, MD (@guildsman) to learn how to cope with fear of #recurrence & #scanxiety in cancer #survivorship.

RSVP: i.nyulangone.org/b9u

Perlmutter Cancer Center at NYU Langone Health repostou

Very interesting data. Confirms clinically what we have seen in clinic @Perlmutter_CC that individuals with lung only recurrences in PDAC do much better for unclear reasons. There must be a unique biology to these lung metastases.

This @aguilera_md @UTSWMedCenter preprint on postoperative patterns of recurrence is a reminder of the high unmet need remaining in patients undergoing surgery for resectable #PancreaticCancer medrxiv.org/content/10.110… Confirming isolated lung versus liver recurrence are distinct.

Aiims1742's tweet image. This @aguilera_md @UTSWMedCenter preprint on postoperative patterns of recurrence is a reminder of the high unmet need remaining in patients undergoing surgery for resectable #PancreaticCancer
medrxiv.org/content/10.110…
Confirming isolated lung versus liver recurrence are distinct.


Perlmutter Cancer Center at NYU Langone Health repostou

FDA Approval of Lurbinectedin/Atezolizumab As First-Line Maintenance Expands Limited Post-Induction Arsenal for ES-SCLC @JSabari @Perlmutter_CC @nyulangone #oncology #lcsm #SCLC hubs.li/Q03TLrXH0


Perlmutter Cancer Center at NYU Langone Health repostou

Save the date! 🗓️ Join us July 24–25, 2026 for a CME symposium on intratumoral therapy for #lungcancer — exploring current techniques, emerging technologies, & the future of bronchoscopic & percutaneous treatment Learn more & register ➡️ bit.ly/47sDrvC #MedEd #PCCM

NYULangonePCCSM's tweet image. Save the date! 🗓️

Join us July 24–25, 2026 for a CME symposium on intratumoral therapy for #lungcancer — exploring current techniques, emerging technologies, & the future of bronchoscopic & percutaneous treatment

Learn more & register ➡️ bit.ly/47sDrvC
#MedEd #PCCM

Grateful to everyone who joined our cancer community symposium at @NYULangoneBK yesterday! Our team highlighted inpatient/outpatient oncology infrastructure, disease-specific programs & ongoing clinical trials driving cancer innovation in Brooklyn.

Perlmutter_CC's tweet image. Grateful to everyone who joined our cancer community symposium at @NYULangoneBK yesterday!

Our team highlighted inpatient/outpatient oncology infrastructure, disease-specific programs & ongoing clinical trials driving cancer innovation in Brooklyn.

Perlmutter Cancer Center at NYU Langone Health repostou

A @NatureMedicine News & Views on @LabLigorio article below by @ammar_asrar @CamilaHidalgoS2 @Perlmutter_CC @nyulangone Understanding end-of-life cancer biology nature.com/articles/s4159…

Aiims1742's tweet image. A @NatureMedicine News & Views on @LabLigorio article below by @ammar_asrar @CamilaHidalgoS2 @Perlmutter_CC @nyulangone 
Understanding end-of-life cancer biology
nature.com/articles/s4159…

New study in @NatureMedicine from @LabLigorio Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life nature.com/articles/s4159… Addressing the fundamental question of why patients with advanced cancers die...

Aiims1742's tweet image. New study in @NatureMedicine from @LabLigorio 
Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life
nature.com/articles/s4159…
Addressing the fundamental question of why patients with advanced cancers die...


Perlmutter Cancer Center at NYU Langone Health repostou

Join @NYUDocs Chiefs Rounds to hear @DrMhidalgo and me talk about the @Perlmutter_CC @nyulangone Gastrointestinal Cancer Center! #PancreaticCancer #ColorectalCancer


Perlmutter Cancer Center at NYU Langone Health repostou

Paper 2: Physiology and immunology of pig-to-human decedent kidney xenotransplant nature.com/articles/s4158…


Perlmutter Cancer Center at NYU Langone Health repostou

Paper 1: Multi-omics analysis of a pig-to-human decedent kidney xenotransplant nature.com/articles/s4158… @nyulangone @Perlmutter_CC @NYULH_Surgery


Perlmutter Cancer Center at NYU Langone Health repostou

We were so honored to welcome and host @dustywater @LiveLung1 on her stop in NYC! She shared her inspiring story and journey with our screening and lung cancer research teams at @nyulangone @Perlmutter_CC to help us kick off #LCAM. Thank you Dusty!! 💪🏻🤩🫁

ElaineShumMD's tweet image. We were so honored to welcome and host @dustywater @LiveLung1 on her stop in NYC!  She shared her inspiring story and journey with our screening and lung cancer research teams at @nyulangone @Perlmutter_CC to help us kick off #LCAM. Thank you Dusty!! 💪🏻🤩🫁

Perlmutter Cancer Center at NYU Langone Health repostou

Congratulations to all the @Clarivate Highly Cited researchers for 2025 at @Perlmutter_CC @nyulangone including our Dean, Alec Kimmelman. @ItaiYanai clarivate.com/highly-cited-r…


Loading...

Something went wrong.


Something went wrong.